Nautilus Biotechnology, Inc. financial data

Symbol
NAUT on Nasdaq
Location
2701 Eastlake Ave East, Seattle, WA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Oct 28, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.7K % -10.4%
Debt-to-equity 17.4 % +10.7%
Return On Equity -33.4 % -15.6%
Return On Assets -28.4 % -14%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 126M shares +0.59%
Common Stock, Shares, Outstanding 126M shares +0.59%
Entity Public Float 113M USD -48.4%
Common Stock, Value, Issued 13K USD 0%
Weighted Average Number of Shares Outstanding, Basic 126M shares +0.68%
Weighted Average Number of Shares Outstanding, Diluted 126M shares +0.68%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 44.4M USD -11.5%
General and Administrative Expense 27M USD -13.8%
Nonoperating Income (Expense) 8.58M USD -24%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -62.8M USD +10.5%
Earnings Per Share, Basic 0 USD/shares +9.09%
Earnings Per Share, Diluted 0 USD/shares +9.09%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 23.9M USD +442%
Cash, Cash Equivalents, and Short-term Investments 131M USD -6.54%
Assets, Current 134M USD -6.85%
Property, Plant and Equipment, Net 3.62M USD -16.2%
Operating Lease, Right-of-Use Asset 24.7M USD -15.8%
Other Assets, Noncurrent 1.18M USD 0%
Assets 201M USD -22.6%
Accounts Payable, Current 893K USD -39.9%
Employee-related Liabilities, Current 3M USD +41.8%
Liabilities, Current 8.98M USD +3.69%
Operating Lease, Liability, Noncurrent 22.8M USD -17.4%
Liabilities 31.8M USD -12.4%
Accumulated Other Comprehensive Income (Loss), Net of Tax 200K USD -72.6%
Retained Earnings (Accumulated Deficit) -318M USD -24.6%
Stockholders' Equity Attributable to Parent 169M USD -24.3%
Liabilities and Equity 201M USD -22.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -13.9M USD +14.3%
Net Cash Provided by (Used in) Financing Activities 18K USD -92.7%
Net Cash Provided by (Used in) Investing Activities 19.5M USD -12.7%
Common Stock, Shares Authorized 1B shares 0%
Common Stock, Shares, Issued 126M shares +0.59%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 5.59M USD -11.7%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 24.9M USD +360%
Deferred Tax Assets, Valuation Allowance 78.4M USD +34.6%
Deferred Tax Assets, Gross 85.9M USD +28.5%
Operating Lease, Liability 27M USD -14.5%
Depreciation 1.72M USD -17.1%
Payments to Acquire Property, Plant, and Equipment 219K USD -66.2%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -63.3M USD +6.08%
Lessee, Operating Lease, Liability, to be Paid 34M USD -17.4%
Property, Plant and Equipment, Gross 11.4M USD +8.86%
Operating Lease, Liability, Current 4.21M USD +6.32%
Lessee, Operating Lease, Liability, to be Paid, Year Two 6.89M USD +0.22%
Lessee, Operating Lease, Liability, to be Paid, Year One 6.87M USD -4.29%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 7M USD -27%
Lessee, Operating Lease, Liability, to be Paid, Year Three 5.82M USD -15.6%
Deferred Tax Assets, Operating Loss Carryforwards 32.7M USD +51.5%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 200M shares 0%
Unrecognized Tax Benefits 3.15M USD +33%
Lessee, Operating Lease, Liability, to be Paid, Year Four 4.54M USD -22%
Operating Lease, Payments 1.8M USD +5.88%
Additional Paid in Capital 487M USD +1.89%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 7.56M USD -12.9%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%